The UFC has issued a statement in regards to Diego Brandao testing over the limit for marijuana metabolites after UFC 195.
UFC featherweight Diego Brandao has apparently violated the UFC’s drug testing policy by failing a test for elevated marijuana metabolites. The USADA, who conducts the testing, notified the UFC of the failure and they issued the following statement:
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) informed Diego Brandao of a potential Anti-Doping Policy violation involving Carboxy-Tetrahydrocannabinol (“Carboxy-THC”) which is a metabolite of marijuana and/or hashish, above the decision limit of 180 ng/mL, stemming from an in-competition sample collected following his fight on January 2, 2016 in Las Vegas.”
Brandao fought Brian Ortega on that UFC 195 card, and was submitted by the American in the third round. The 28-year-old was the winner of TUF 14 and has gone 6-4 in 10 UFC bouts.
The statement also says that the USADA will share their info with the Nevada State Athletic Commission so they can determine the appropriate punishment for the violation.